These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 21710107)

  • 1. Primary cutaneous melanoma arising in agminated melanocytic nevi: CDKN2A and CDK4 mutation screening.
    Rezze GG; Leon A; Silva DC; Neves RI; Molina GC; Carraro DM; Landman G; Duprat JP
    Acta Derm Venereol; 2012 Jan; 92(1):98-9. PubMed ID: 21710107
    [No Abstract]   [Full Text] [Related]  

  • 2. CDKN2A/CDK4 molecular study on 155 Italian subjects with familial and/or primary multiple melanoma.
    Majore S; De Simone P; Crisi A; Eibenschutz L; Binni F; Antigoni I; De Bernardo C; Catricalà C; Grammatico P
    Pigment Cell Melanoma Res; 2008 Apr; 21(2):209-11. PubMed ID: 18363633
    [No Abstract]   [Full Text] [Related]  

  • 3. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 7-2004. A 48-year-old woman with multiple pigmented lesions and a personal and family history of melanoma.
    Tsao H; Sober AJ; Niendorf KB; Zembowicz A
    N Engl J Med; 2004 Feb; 350(9):924-32. PubMed ID: 14985491
    [No Abstract]   [Full Text] [Related]  

  • 4. A search for CDKN2A/p16INK4a mutations in melanocytic nevi from patients with melanoma and spouse controls by use of laser-captured microdissection.
    Wang H; Presland RB; Piepkorn M
    Arch Dermatol; 2005 Feb; 141(2):177-80. PubMed ID: 15724013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population-based prevalence of CDKN2A and CDK4 mutations in patients with multiple primary melanomas.
    Helsing P; Nymoen DA; Ariansen S; Steine SJ; Maehle L; Aamdal S; Langmark F; Loeb M; Akslen LA; Molven A; Andresen PA
    Genes Chromosomes Cancer; 2008 Feb; 47(2):175-84. PubMed ID: 18023021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased melanocytic nevi and nevus density in a G-34T CDKN2A/p16 melanoma-prone pedigree.
    Florell SR; Meyer LJ; Boucher KM; Grossman D; Cannon-Albright LA; Harris RM; Samlowski WE; Zone JJ; Leachman SA
    J Invest Dermatol; 2008 Aug; 128(8):2122-5. PubMed ID: 18337833
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of the CDKN2A locus in patients with multiple primary melanomas.
    Puig S; Malvehy J; Badenas C; Ruiz A; Jimenez D; Cuellar F; Azon A; Gonzàlez U; Castel T; Campoy A; Herrero J; Martí R; Brunet-Vidal J; Milà M
    J Clin Oncol; 2005 May; 23(13):3043-51. PubMed ID: 15860862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptome sequencing of melanocytic nevi and melanomas from Grm1 transgenic mice to determine melanoma driver mutations.
    de Jel MM; Engelmann JC; Kunz M; Schiffner S; Kuphal S; Bosserhoff AK
    Pigment Cell Melanoma Res; 2014 Jul; 27(4):678-80. PubMed ID: 24661573
    [No Abstract]   [Full Text] [Related]  

  • 9. A natural history of melanomas and dysplastic nevi: an atlas of lesions in melanoma-prone families.
    Tucker MA; Fraser MC; Goldstein AM; Struewing JP; King MA; Crawford JT; Chiazze EA; Zametkin DP; Fontaine LS; Clark WH
    Cancer; 2002 Jun; 94(12):3192-209. PubMed ID: 12115352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutational analysis of the N-ras, p53, p16INK4a, CDK4, and MC1R genes in human congenital melanocytic naevi.
    Papp T; Pemsel H; Zimmermann R; Bastrop R; Weiss DG; Schiffmann D
    J Med Genet; 1999 Aug; 36(8):610-4. PubMed ID: 10465111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple primary melanomas in a CDKN2A mutation carrier exposed to ionizing radiation.
    Eliason MJ; Hansen CB; Hart M; Porter-Gill P; Chen W; Sturm RA; Bowen G; Florell SR; Harris RM; Cannon-Albright LA; Swinyer L; Leachman SA
    Arch Dermatol; 2007 Nov; 143(11):1409-12. PubMed ID: 18025365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Melanocytic tumours and genetics: new findings].
    Dereure O
    Ann Dermatol Venereol; 2012 Mar; 139(3):243-4. PubMed ID: 22401696
    [No Abstract]   [Full Text] [Related]  

  • 13. Metastatic melanoma in association with a giant congenital melanocytic nevus in an adult: controversial CGH findings.
    Machan S; Molina-Ruiz AM; Fernández-Aceñero MJ; Encabo B; LeBoit P; Bastian BC; Requena L
    Am J Dermatopathol; 2015 Jun; 37(6):487-94. PubMed ID: 25062263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a CDK4 R24H mutation-positive melanoma family by analysis of early-onset melanoma patients in Latvia.
    Pjanova D; Molven A; Akslen LA; Engele L; Streinerte B; Azarjana K; Heisele O
    Melanoma Res; 2009 Apr; 19(2):119-22. PubMed ID: 19238106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Increased risk of developing a second primary cutaneous nevus-associated melanoma in patients previously diagnosed with the disease].
    Echeverría B; Botella-Estrada R; Serra-Guillén C; Martorell A; Traves V; Requena C; Sanmartín O; Llombart B; Guillén C; Nagore E
    Actas Dermosifiliogr; 2010 Oct; 101(8):710-6. PubMed ID: 20965014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinguishing melanocytic nevi from melanoma by DNA copy number changes: comparative genomic hybridization as a research and diagnostic tool.
    Bauer J; Bastian BC
    Dermatol Ther; 2006; 19(1):40-9. PubMed ID: 16405569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant melanoma arising from an NRAS-mutated medium-sized congenital melanocytic nevus.
    Kiyohara T; Takata M; Itoh H; Kawami K; Ido H; Ishida H; Kumakiri M
    J Dermatol; 2012 Dec; 39(12):1034-5. PubMed ID: 22452623
    [No Abstract]   [Full Text] [Related]  

  • 18. Melanoma(s) associated with a quadrant or segmental distribution of atypical melanocytic nevi: case report and review of the literature.
    Zalaudek I; Nicolino R; Ferrara G; Capoluongo P; Roma P; Sgambato A; Argenziano G
    Dermatol Surg; 2009 Feb; 35(2):268-72. PubMed ID: 19215269
    [No Abstract]   [Full Text] [Related]  

  • 19. Unilateral agminated melanocytic nevi.
    Cabanillas Gonzáles M; Monteagudo B; de las Heras C; Cacharrón JM
    Dermatology; 2009; 218(4):387-8. PubMed ID: 18974631
    [No Abstract]   [Full Text] [Related]  

  • 20. CDKN2A mutations in multiple primary melanomas.
    Monzon J; Liu L; Brill H; Goldstein AM; Tucker MA; From L; McLaughlin J; Hogg D; Lassam NJ
    N Engl J Med; 1998 Mar; 338(13):879-87. PubMed ID: 9516223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.